The chemical substance known as "Acetic acid, [4-[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazol-1-yl]sulfonyl]phenoxy]-, sodium salt" with CAS number 651728-41-5 is a complex organic compound characterized by its structural components, which include a benzimidazole moiety, a sulfonyl group, and a sodium salt form of acetic acid. This compound exhibits properties typical of both organic acids and sulfonamides, potentially displaying biological activity due to its intricate structure. The presence of methoxy and pyridine groups suggests possible interactions with biological targets, making it of interest in pharmaceutical research. Its sodium salt form indicates enhanced solubility in aqueous environments, which is beneficial for biological applications. The compound's synthesis and characterization would involve standard organic chemistry techniques, and its stability, reactivity, and potential applications would be determined through further experimental studies. Overall, this substance represents a unique combination of functional groups that may contribute to its efficacy in various chemical and biological contexts.

Acetic acid,[4-[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazol-1-yl]sulfonyl]phenoxy]-, sodium salt

651728-41-5: The chemical substance known as "Acetic acid, [4-[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazol-1-yl]sulfonyl]phenoxy]-, sodium salt" with CAS number 651728-41-5 is a complex organic compound characterized by its structural components, which include a benzimidazole moiety, a sulfonyl group, and a sodium salt form of acetic acid. This compound exhibits properties typical of both organic acids and sulfonamides, potentially displaying biological activity due to its intricate structure. The presence of methoxy and pyridine groups suggests possible interactions with biological targets, making it of interest in pharmaceutical research. Its sodium salt form indicates enhanced solubility in aqueous environments, which is beneficial for biological applications. The compound's synthesis and characterization would involve standard organic chemistry techniques, and its stability, reactivity, and potential applications would be determined through further experimental studies. Overall, this substance represents a unique combination of functional groups that may contribute to its efficacy in various chemical and biological contexts.

AGN-201904Z is a slow-release, acid-resistant pro-PPI that turns into omeprazole, offering extended acid suppression.

CAS 651728-41-5

Acetic acid,[4-[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazol-1-yl]sulfonyl]phenoxy]-, sodium salt

AGN-201904Z

Ref: TM-T26577